Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC

Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1NL61td